Stay updated on NYX-2925 Efficacy & Safety in DPN Clinical Trial
Sign up to get notified when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.

Latest updates to the NYX-2925 Efficacy & Safety in DPN Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study record page now displays a 403 Forbidden error page, replacing the study details with a standard error screen and site footer.SummaryDifference18%

- Check36 days agoChange DetectedThe revision label changed from v3.6.5 to v3.6.6, indicating a small backend or UI update to the page; no study text or results are affected.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.6.5 added. The change represents an update to the page's revision metadata rather than substantive study information.SummaryDifference16%

- Check72 days agoChange DetectedThe page's revision tag in the footer was updated to v3.6.4, replacing the previous v3.6.3.SummaryDifference0.0%

- Check93 days agoChange DetectedThe revision label on the page was updated from v3.6.2 to v3.6.3, signaling a minor patch/update to the page metadata. The core study details and content remain unchanged.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision label updated from Revision: v3.6.0 to Revision: v3.6.2, indicating a newer page build. This likely reflects backend or UI updates rather than substantive changes to the study information.SummaryDifference0.0%

Stay in the know with updates to NYX-2925 Efficacy & Safety in DPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.